New research shows that the time of day when blood samples are taken significantly impacts the levels of Alzheimer's biomarkers, including p-tau217, which is crucial for early diagnosis. Biomarker levels were found to be lowest in the morning and highest in the evening, indicating that timing could affect dementia diagnosis and monitoring.
New research shows that the time of day when blood samples are taken significantly impacts the levels of Alzheimer's biomarkers, including p-tau217, which is crucial for early diagnosis. Biomarker levels were found to be lowest in the morning and highest in the evening, indicating that timing could affect dementia diagnosis and monitoring.
Share this Article
Recommended